A vitamin A deficient diet enhances proinflammatory cytokine, Mu opioid receptor, and HIV-1 expression in the HIV-1 transgenic rat

Journal of Neuroimmunology

Volumn 185, Issue 1-2, 2007, Pages 29-36

  Royal III, Walter ^a   Wang, Huiyun ^a   Jones, Odell ^b   Tran, Hieu ^b   Bryant, Joseph L ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF HUMAN VIROLOGY   (United States)

Author keywords

Cytokines; HIV 1; Opioid receptor; Retinoids; Transgenic rat; Vitamin A

Indexed keywords

CYTOKINE; GAMMA INTERFERON; MESSENGER RNA; MITOGENIC AGENT; MU OPIATE RECEPTOR; NEF PROTEIN; RETINOL; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOPATHOGENESIS; INTERFERON PRODUCTION; NONHUMAN; PRIORITY JOURNAL; RAT; RETINOL DEFICIENCY; TRANSGENIC RAT; VIRUS EXPRESSION; VIRUS GENE; WILD TYPE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; HIV-1; INFLAMMATION; POLYMERASE CHAIN REACTION; RATS; RECEPTORS, OPIOID, MU; T-LYMPHOCYTES; VIRAL PROTEINS; VITAMIN A DEFICIENCY;

EID: 33947651231     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.01.001     Document Type: Article

References (51)

1. Arrigo S.J., Weitsman S., Rosenblatt J.D., and Chen I.S. Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method. J. Virol. 63 (1989) 4875-4881
2. Arrigo S.J., Weitsman S., Zack J.A., and Chen I.S. Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1. J. Virol. 64 (1990) 4585-4588
3. Austenaa L.M., Carlsen H., Ertesvag A., Alexander G., Blomhoff H.K., and Blomhoff R. Vitamin A status significantly alters nuclear factor-kappaB activity assessed by in vivo imaging. FASEB J. 18 (2004) 1255-1257
4. Bae J.S., Ahn S.J., Yim H., Jang K.H., and Jin H.K. Prevention of intraperitoneal adhesions and abscesses by polysaccharides isolated from Phellinus spp in a rat peritonitis model. Ann. Surg. 241 (2005) 534-540
5. Beenken S.W., Huang P., Sellers M., Peters G., Listinsky C., Stockard C., Hubbard W., Wheeler R., and Grizzle W. Retinoid modulation of biomarkers in oral leukoplakia/dysplasia. J. Cell. Biochem. Suppl 19 (1994) 270-277
6. Brinckerhoff C.E., McMillan R.M., Dayer J.-M., and Harris Jr. E.D. Inhibition by retinoic acid of collagenase production in rheumatoid synovial cells. N. Engl. J. Med. 303 (1980) 432-436
7. Cantorna M.T., and Hayes C.E. Vitamin A deficiency exacerbates murine Lyme arthritis. J. Infect. Dis. 174 (1996) 747-751
8. Cantorna M.T., Nashold F.E., and Hayes C.E. In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J. Immunol. 152 (1994) 1515-1522
9. Cantorna M.T., Nashold F.E., and Hayes C.E. Vitamin A deficiency results in a priming environment conducive for Th1 cell development. Eur. J. Immunol. 25 (1995) 1673-1679
10. Carman J.A., and Hayes C.E. Abnormal regulation of IFN-gamma secretion in vitamin A deficiency. J. Immunol. 147 (1991) 1247-1252
11. Comstock G.W., Burke A.E., Hoffman S.C., Helzlsouer K.J., Bendich A., Masi A.T., Norkus E.P., Malamet R.L., and Gershwin M.E. Serum concentrations of alpha tocopherol, beta carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus. Ann. Rheum. Dis. 56 (1997) 323-325
12. Desai-Yajnik V., and Samuels H.H. The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements. Mol. Cell. Biol. 13 (1993) 5057-5069
13. Driscoll H.K., Chertow B.S., Jelic T.M., Baltaro R.J., Chandor S.B., Walker E.M., Dadgari J.M., and Pofahl A.B. Vitamin A status affects the development of diabetes and insulitis in BB rats. Metabolism 45 (1996) 248-253
14. Duvic M., Friedman-Kien A.E., Looney D.J., Miles S.A., Myskowski P.L., Scadden D.T., Von Roenn J., Galpin J.E., Groopman J., Loewen G., Stevens V., Truglia J.A., and Yocum R.C. Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. Arch. Dermatol. 136 (2000) 1461-1469
15. Fawzi W. Micronutrients and human immunodeficiency virus type 1 disease progression among adults and children. Clin. Infect. Dis. 37 Suppl 2 (2003) S112-S116
16. Gershwin M.E., Lentz D.R., Beach R.D., and Hurley L.S. Nutritional factors and autoimmunity. Dietary vitamin A deprivation induces a selective increase in IgM autoantibodies and hypergammaglobulinemia in New Zealand black mice. J. Immunol. 133 (1984) 222-226
17. Hudson L., Liu J., Nath A., Jones M., Raghavan R., Narayan O., Male D., and Everall I. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues. J. Neurovirology 6 (2000) 145-155
18. Humphrey J.H., Iliff P.J., Marinda E.T., Mutasa K., Moulton L.H., Chidawanyika H., Ward B.J., Nathoo K.J., Malaba L.C., Zijenah L.S., Zvandasara P., Ntozini R., Mzengeza F., Mahomva A.I., Ruff A.J., Mbizvo M.T., and Zunguza C.D. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J. Infect. Dis. 193 (2006) 860-871
19. Jacque J.M., Triques K., and Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 418 (2002) 435-438
20. Kinoshita K., Yoo B.S., Nozaki Y., Sugiyama M., Ikoma S., Ohno M., Funauchi M., and Kanamaru A. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice. J. Immunol. 170 (2003) 5793-5798
21. Kitano K., Baldwin G.C., Raines M.A., and Golde D.W. Differentiating agents facilitate infection of myeloid leukemia cell lines by monocytotropic HIV-1 strains. Blood 76 (1990) 1980-1988
22. Klein S.A., Dobmeyer J.M., Dobmeyer T.S., Pape M., Ottmann O.G., Helm E.B., Hoelzer D., and Rossol R. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 11 (1997) 1111-1118
23. Kraus J., Borner C., Giannini E., Hickfang K., Braun H., Mayer P., Hoehe M.R., Ambrosch A., Konig W., and Hollt V. Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J. Biol. Chem. 276 (2001) 43901-43908
24. Ladias J.A. Convergence of multiple nuclear receptor signaling pathways onto the long terminal repeat of human immunodeficiency virus-1. J. Biol. Chem. 269 (1994) 5944-5951
25. Lee M.O., Hobbs P.D., Zhang X.K., Dawson M.I., and Pfahl M. A synthetic retinoid antagonist inhibits the human immunodeficiency virus type 1 promoter. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 5632-5636
26. Letvin N.L., and Walker B.D. Immunopathogenesis and immunotherapy in AIDS virus infections. Nat. Med. 9 (2003) 861-866
27. Li Y., Wang X., Tian S., Guo C.J., Douglas S.D., and Ho W.Z. Methadone enhances human immunodeficiency virus infection of human immune cells. J. Infect. Dis. 185 (2002) 118-122
28. Maciaszek J.W., Coniglio S.J., Talmage D.A., and Viglianti G.A. Retinoid-induced repression of human immunodeficiency virus type 1 core promoter activity inhibits virus replication. J. Virol. 72 (1998) 5862-5869
29. Mahajan S.D., Schwartz S.A., Shanahan T.C., Chawda R.P., and Nair M.P. Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor. J. Immunol. 169 (2002) 3589-3599
30. Mahajan S.D., Aalinkeel R., Reynolds J.L., Nair B.B., Fernandez S.F., Schwartz S.A., and Nair M.P. Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells. Curr. HIV Educ. Res. 3 (2005) 277-288
31. Mazzucchelli R., Amadio M., Curreli S., Denaro F., Bemis K., Reid W., Bryant J., Riva A., Galli M., and Zella D. Establishment of an ex vivo model of monocytes-derived macrophages differentiated from peripheral blood mononuclear cells (PBMCs) from HIV-1 transgenic rats. Mol. Immunol. 41 (2004) 979-984
32. Nakagawa M., Oono H., and Nishio A. Enhanced production of IL-1beta and IL-6 following endotoxin challenge in rats with dietary magnesium deficiency. J. Vet. Med. Sci. 63 (2001) 467-469
33. Orchard K., Lang G., Harris J., Collins M., and Latchman D. A palindromic element in the human immunodeficiency virus long terminal repeat binds retinoic acid receptors and can confer retinoic acid responsiveness on a heterologous promoter. J. Acquir. Immune Defic. Syndr. 6 (1993) 440-445
34. Peterson P.K., Gekker G., Hu S., Anderson W.R., Kravitz F., Portoghese P.S., Balfour Jr. H.H., and Chao C.C. Morphine amplifies HIV-1 expression in chronically infected promonocytes cocultured with human brain cells. J. Neuroimmunol. 50 (1994) 167-175
35. Poli G., Kinter A.L., Justement J.S., Bressler P., Kehrl J.H., and Fauci A.S. Retinoic acid mimics transforming growth factor beta in the regulation of human immunodeficiency virus expression in monocytic cells. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 2689-2693
36. Reid W., Sadowska M., Denaro F., Rao S., Foulke Jr. J., Hayes N., Jones O., Doodnauth D., Davis H., Sill A., O'Driscoll P., Huso D., Fouts T., Lewis G., Hill M., Kamin-Lewis R., Wei C., Ray P., Gallo R.C., Reitz M., and Bryant J. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 9271-9276
37. Reid W., Abdelwahab S., Sadowska M., Huso D., Neal A., Ahearn A., Bryant J., Gallo R.C., Lewis G.K., and Reitz M. HIV-1 transgenic rats develop T cell abnormalities. Virology 321 (2004) 111-119
38. Roy S., Cain K.J., Chapin R.B., Charboneau R.G., and Barke R.A. Morphine modulates NF kappa B activation in macrophages. Biochem. Biophys. Res. Commun. 245 (1998) 392-396
39. Royal III W., Gartner S., and Gajewski C.D. Retinol measurements and retinoid receptor gene expression in patients with multiple sclerosis. Mult. Scler. 8 (2002) 452-458
40. Royal III W., Leander M.V., and Bissonnette R. Retinoid-induced mu opioid receptor expression by phytohemagglutinin-stimulated U937 cells. J. Neurovirology 11 (2005) 157-165
41. Semba R.D., Graham N.M., Caiaffa W.T., Margolick J.B., Clement L., and Vlahov D. Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch. Int. Med. Exp. 153 (1993) 2149-2154
42. Semba R.D., Ward B.J., Griffin D.E., Scott A.L., Natadisastra G., West J.K.P., and Sommer A. Abnormal T-cell subset proportions in vitamin-A-deficient children. Lancet 341 (1993) 5-8
43. Semmel M., Macho A., Coulaud D., Alileche A., Plaisance S., Aguilar J., and Jasmin C. Effect of retinoic acid on HL-60 cells infected with human immunodeficiency virus type 1. Blood 84 (1994) 2480-2488
44. Towers G., Harris J., Lang G., Collins M.K., and Latchman D.S. Retinoic acid inhibits both the basal activity and phorbol ester-mediated activation of the HIV long terminal repeat promoter. AIDS 9 (1995) 129-136
45. Vladutiu A., and Cringulescu N. Suppression of experimental allergic encephalomyelitis by vitamin A. Experimentia 24 (1968) 718-719
46. Walmsley S., Northfelt D.W., Melosky B., Conant M., Friedman-Kien A.E., and Wagner B. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group. J. Acquir. Immune Defic. Syndr. 22 (1999) 235-246
47. Wang J., Barke R.A., Charboneau R., Loh H.H., and Roy S. Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP-dependent pathways. J. Biol. Chem. 278 (2003) 37622-37631
48. Warren T.R. Multiple sclerosis and infants fed on diets deficient in vitamin A or in selenium and vitamin E. Med. Hypotheses 8 (1982) 443-454
49. Xu J., Luznik L., Wong-Staal F., and Gill G.N. Hormone receptor regulation of the human immunodeficiency virus type 1 and type 2 long terminal repeats. J. Biomed. Sci. 3 (1996) 323-331
50. Yamaguchi K., Groopman J.E., and Byrn R.A. The regulation of HIV by retinoic acid correlates with cellular expression of the retinoic acid receptors. AIDS 8 (1994) 1675-1682
51. Zhao Z., and Ross A.C. Retinoic acid repletion restores the number of leukocytes and their subsets and stimulates natural cytotoxicity in vitamin A-deficient rats. J. Nutr. 125 (1995) 2064-2073